Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization
Background. Pathological neovascularization, which involves a disruption in the balance between angiogenic and antiangiogenic factors under pathological conditions, is the basis of many intraocular diseases. Pigment epithelium-derived factor (PEDF) is a potent natural, endogenous inhibitor of neovas...
Saved in:
Main Authors: | Feng Zhao, Wenlei Fei, Zhouyue Li, Hanyang Yu, Lei Xi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2022/1193760 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept
by: Juliana Wons, et al.
Published: (2017-01-01) -
Aqueous Levels of Pigment Epithelium-Derived Factor and Macular Choroidal Thickness in High Myopia
by: Wei Chen, et al.
Published: (2015-01-01) -
Increased Serum Pigment Epithelium-Derived Factor in Women with Gestational Diabetes Is Associated with Type 2 Diabetes
by: Tong-Huan Li, et al.
Published: (2015-01-01) -
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01) -
Congenital Simple Hamartoma of Retinal Pigment Epithelium: Clinical and Imaging Findings
by: Mehmet Yasin Teke, et al.
Published: (2012-01-01)